ClinicalTrials.gg
CompletedNCT04006509Updated May 21, 2024Results posted

Prenatal Breast Pump Education of Mothers and Their Support Person

An interventional study of Prenatally Delivered Lactation Educational Program in Preterm Birth and Breast Feeding, sponsored by University of Florida. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-21.

Sponsored by University of Florida · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Nov 2018, registered Jul 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The study will follow a prospective cohort of racially and economically diverse mothers of premature infants for 3 weeks following delivery to test whether antenatal education of the support person of mothers may decrease time to initiation of breast pumping, decrease time to lactogenesis stage II and increase breast milk production.

Read the detailed description

Compelling evidence exists that breast milk helps protect premature infants from prematurity-specific morbidities, including feeding intolerance, late onset sepsis, and necrotizing enterocolitis. Unfortunately, mothers of VLBW infants often exhibit delayed lactogenesis stage II (when the milk "comes in") and inadequate breast milk production. Earlier initiation of breast milk expression following delivery is associated with increased lactation success. However, lack of nursing time and lack of hospital personal are significant barriers to the early initiation of milk expression in this population. The proposed study will follow a prospective cohort of racially and economically diverse mothers of premature infants for 3 weeks following delivery to test 1 primary aim and 1 secondary aim. Aim 1: will evaluate the feasibility of antenatal BM pumping education for SPs of mothers of preterm infants. Issues related to recruitment, randomization acceptance of the intervention, and refinement of the education materials and process will be scrutinized. Aim 2 will estimate variability of outcome measurements and effect sizes needed to calculate the sample size for a subsequent larger, adequately powered, randomized clinical trial. Eligible women and their SP will be randomly assigned to one of two groups. Group 1 will receive a prenatally delivered lactation educational program including video recordings, a demonstration of how the pump works and will have a breast pump available in their room. The volume of breast milk produced, timing of lactation stage II, duration of lactation and stress during initial expression will be measured. In addition, breast milk sodium levels will be analyzed on Day 1-7, Day 14 and 21.

02

Conditions studied

  • Preterm Birth
  • Breast Feeding

Keywords

  • preterm breast milk
03

In context

Premature Birth

2,610 studies on the registry are indexed under Premature Birth; 507 are open to participants now.

This study's enrollment of 90 is close to the median of 84 across 1,722 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

University of Florida is the lead sponsor of 1,285 studies on the registry; 199 are open to participants now.

Of its 177 completed or terminated interventional studies of FDA-regulated products, 141 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • English speaking
  • stated intent to breastfeed
  • anticipating the birth of a premature infant \< 35 weeks gestation.

Exclusion criteria

Exclusion Criteria:

  • known illicit maternal drug use
  • history of breast reduction or augmentation
  • positive HIV status
  • infant not expected to live over 2 weeks following delivery.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Antenatal Education Group

    Patients will receive a prenatally delivered lactation educational program.

    Behavioral: Prenatally Delivered Lactation Educational Program

  • No intervention
    Standard of Care Group

    Patients will receive standard of care and not a prenatally delivered lactation educational program.

Interventions

  • BehavioralPrenatally Delivered Lactation Educational Program

    The support person (SP) of mothers at risk for preterm birth will be educated on how to use a breast pump and instructions regarding breast milk expression and have a pump in their hospital room

    Also known as: Antenatal Education

06

What researchers measure

Primary outcomes

  1. Onset of Lactogenesis Stage II Through Volume Attainment

    Time in hours until mothers pump at least 20 mL of milk in 2 consecutive pumping sessions

    Time frame: Up to 96 Hours

Secondary outcomes

  1. Breast Milk Production on Day 1

    Volume of breast milk produced from 0-24 hours postpartum

    Time frame: 0-24 hours postpartum

  2. Time to Breast Pumping Initiation

    Time to mothers beginning to pump breasts after delivery

    Time frame: first 24 hours after delivery

  3. Breast Milk Production Day 2

    Volume of breast milk produced on day 2 postpartum

    Time frame: Day 2 postpartum

  4. Milk Production Day 3

    Volume of milk produced on Day 3 postpartum

    Time frame: 3 days postpartum

  5. Breast Milk Production Day 4

    Volume of breast milk produced on Day 4 postpartum

    Time frame: Day 4 postpartum

  6. Breast Milk Production on Day 5

    Volume of breast milk produced on Day 5 postpartum

    Time frame: Day 5 postpartum

  7. Breast Milk Production Day 6

    Volume of breast milk produced on Day 6 postpartum

    Time frame: Day 6 postpartum

  8. Breast Milk Production Day 7

    Volume of milk produced on Day 7 postpartum

    Time frame: Day 7 postpartum

  9. Breast Milk Production Day 14

    Volume of breast milk produced on Day 14 postpartum

    Time frame: Day 14 postpartum

  10. Breast Milk Production Day 21

    Volume of breast milk produced on Day 21 postpartum

    Time frame: 21 days postpartum

07

Results

Posted May 21, 2024

Participant flow

Participant flow — Overall Study
MilestoneAntenatal Education GroupStandard of Care Group
Started4925
Completed3625
Not completed130

Outcome measures

PrimaryOnset of Lactogenesis Stage II Through Volume Attainment

Time in hours until mothers pump at least 20 mL of milk in 2 consecutive pumping sessions

Time frame:
Up to 96 Hours
Reported as:
Mean · hours
Onset of Lactogenesis Stage II Through Volume Attainment
hoursAntenatal Education GroupStandard of Care Group
Onset of Lactogenesis Stage II Through Volume Attainment84.8 (58.8 to 102.6)81 (61.3 to 101.3)
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Wilcoxon (Mann-Whitney) · p = 0.985
SecondaryBreast Milk Production on Day 1

Volume of breast milk produced from 0-24 hours postpartum

Time frame:
0-24 hours postpartum
Reported as:
Median · mL
Breast Milk Production on Day 1
mLAntenatal Education GroupStandard of Care Group
Breast Milk Production on Day 115.3 ± 16.524.3 ± 28.1
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Marginal Two-Part Model · p = 0.539
SecondaryTime to Breast Pumping Initiation

Time to mothers beginning to pump breasts after delivery

Time frame:
first 24 hours after delivery
Reported as:
Mean · Hours
Time to Breast Pumping Initiation
HoursAntenatal Education GroupStandard of Care Group
Time to Breast Pumping Initiation4 ± 3.53.8 ± 3.4
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Wilcoxon (Mann-Whitney) · p = 0.959
SecondaryBreast Milk Production Day 2

Volume of breast milk produced on day 2 postpartum

Time frame:
Day 2 postpartum
Reported as:
Mean · mL
Breast Milk Production Day 2
mLAntenatal Education GroupStandard of Care Group
Breast Milk Production Day 232.7 ± 35.639.5 ± 43.7
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Marginal Two-Part Model · p = 0.743
SecondaryMilk Production Day 3

Volume of milk produced on Day 3 postpartum

Time frame:
3 days postpartum
Reported as:
Mean · mL
Milk Production Day 3
mLAntenatal Education GroupStandard of Care Group
Milk Production Day 355.88 ± 57.959.7 ± 58
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Marginalized Two-Part Model · p = 0.886
SecondaryBreast Milk Production Day 4

Volume of breast milk produced on Day 4 postpartum

Time frame:
Day 4 postpartum
Reported as:
Mean · mL
Breast Milk Production Day 4
mLAntenatal Education GroupStandard of Care Group
Breast Milk Production Day 4101.8 ± 126.697.4 ± 87.2
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Marginalized Two-Part Model · p = 0.107
SecondaryBreast Milk Production on Day 5

Volume of breast milk produced on Day 5 postpartum

Time frame:
Day 5 postpartum
Reported as:
Mean · mL
Breast Milk Production on Day 5
mLAntenatal Education GroupStandard of Care Group
Breast Milk Production on Day 5149.9 ± 167.4138.5 ± 113.2
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Marginalized Two-Part Model · p = 0.687
SecondaryBreast Milk Production Day 6

Volume of breast milk produced on Day 6 postpartum

Time frame:
Day 6 postpartum
Reported as:
Mean · mL
Breast Milk Production Day 6
mLAntenatal Education GroupStandard of Care Group
Breast Milk Production Day 6245.3 ± 317.9266.8 ± 300.1
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Marginalized Two-Part Model · p = 0.871
SecondaryBreast Milk Production Day 7

Volume of milk produced on Day 7 postpartum

Time frame:
Day 7 postpartum
Reported as:
Mean · mL
Breast Milk Production Day 7
mLAntenatal Education GroupStandard of Care Group
Breast Milk Production Day 7345 ± 558.4361.9 ± 342.3
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Marginalized Two-Part Model · p = 0.376
SecondaryBreast Milk Production Day 14

Volume of breast milk produced on Day 14 postpartum

Time frame:
Day 14 postpartum
Reported as:
Mean · mL
Breast Milk Production Day 14
mLAntenatal Education GroupStandard of Care Group
Breast Milk Production Day 14431 ± 416.7428 ± 349.9
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Marginalized Two-Part Model · p = 0.770
SecondaryBreast Milk Production Day 21

Volume of breast milk produced on Day 21 postpartum

Time frame:
21 days postpartum
Reported as:
Mean · mL
Breast Milk Production Day 21
mLAntenatal Education GroupStandard of Care Group
Breast Milk Production Day 21725 ± 1070.1573.9 ± 402.1
Statistical analysis
  • Antenatal Education Group vs Standard of Care Group · Marginalized Two-Part Model · p = 0.237

Adverse events

Collected over 21 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Antenatal Education Group0/36 (0%)0/36 (0%)0/36 (0%)
Standard of Care Group0/25 (0%)0/25 (0%)0/25 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Antenatal Education GroupStandard of Care GroupTotal
Mean27.2 ± 6.429 ± 628 ± 6.1
Sex: Female, Male
Sex: Female, Male(Participants)Antenatal Education GroupStandard of Care GroupTotal
Female362561
Male000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Antenatal Education GroupStandard of Care GroupTotal
American Indian or Alaska Native000
Asian101
Native Hawaiian or Other Pacific Islander000
Black or African American221436
White131124
More than one race000
Unknown or Not Reported000
08

Study locations

1 site
  • UF Health at the University of Florida
    Gainesville, Florida 32610, United States
09

References and documents

Publications

  • Parker LA, Bendixen M, Sullivan S, Cacho N, Mueller M. Antepartum Breast Pump Education for Mothers and Their Support Person: Effect on Time to First Expression and Lactation Outcomes-A Randomized Controlled Pilot Study. Breastfeed Med. 2022 May;17(5):437-445. doi: 10.1089/bfm.2021.0275. Epub 2022 Apr 26. PubMed 35475721 ↗

Study documents

  • Protocol and statistical analysis plan · Jun 16, 2019
  • Informed consent form · Oct 19, 2011

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2018 to primary completion in May 2022, 41 months.

Results were first posted in May 2024, 2 years after primary completion.

Of 753 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 41 months is above that.

Counting every sponsor, half of 775 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2019
First posted
Jul 5, 2019
StartActual
Nov 6, 2018
Primary completionActual
May 4, 2022
CompletionActual
May 4, 2022
Results first posted
May 21, 2024
Last update
May 21, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04006509
Responsible party
Sponsor
First posted
Jul 5, 2019
Start date
Nov 6, 2018
Primary completion
May 4, 2022
Completion
May 4, 2022
Results posted
May 21, 2024
Last update
May 21, 2024

Study contacts

Leslie A Parker
principal investigator · University of Florida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion